What does APOTHEEK PELGRIMS do?

APOTHEEK PELGRIMS is a pharmacy in Hulshout. Public Limited, started on 18 April 1988, 1 establishment.

What is the address of APOTHEEK PELGRIMS?

The registered office of APOTHEEK PELGRIMS is located at Vennekensstraat 36a, 2235 Hulshout.

Is APOTHEEK PELGRIMS still active?

Yes. According to the CBE (30 October 2026) APOTHEEK PELGRIMS is active, legal situation “Normale toestand”, started on 18 April 1988.

Is APOTHEEK PELGRIMS registered on Peppol?

Yes, APOTHEEK PELGRIMS is registered on the Peppol network with ID 0208:0434071832.

What is the enterprise number of APOTHEEK PELGRIMS?

The enterprise number of APOTHEEK PELGRIMS is BE0434071832.

When was APOTHEEK PELGRIMS founded?

APOTHEEK PELGRIMS was founded on 18 April 1988.

Who are the directors of APOTHEEK PELGRIMS?

According to the 2025 annual accounts, the directors of APOTHEEK PELGRIMS are: Farmapel BV.

Is APOTHEEK PELGRIMS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 April 1988; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK PELGRIMS make in 2025?

APOTHEEK PELGRIMS posted a profit after taxes of € 93,434 in financial year 2025.

What is the revenue of APOTHEEK PELGRIMS?

As a small company, APOTHEEK PELGRIMS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 281,286.

How many employees does APOTHEEK PELGRIMS have?

According to the 2025 annual accounts, APOTHEEK PELGRIMS has 0.7 full-time equivalents (FTE).

APOTHEEK PELGRIMS (Public Limited) - Hulshout

Dossier APOTHEEK PELGRIMS, printed on 30 October 2026 from databakkes.be/en/0434071832/apotheek-pelgrims. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK PELGRIMS from Hulshout, company number BE0434071832, closed financial year 2025 with a result of € 93,434 after tax. For that financial year APOTHEEK PELGRIMS recorded a gross margin of € 281,286 and equity of € 461,373. Compared with financial year 2024, the result moved from € 74,175 to € 93,434. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 5, 2026.

What it is worth Healthy

€ 461,373

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 93,434

▲ 26% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 52,017

▼ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 93,434 paid out

100 % of the profit went to the shareholders, mostly to FARMAPEL (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

0.7

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 48,625

▲ 1% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 515

▼ 72% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 281,294

▼ 12% vs 2024

€ 50,609 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 128,413

▲ 1% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 5,709

▲ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 221,618 Gross margin 2022: € 221,618 First fiscal year in the series	€ 246,539 Gross margin 2023: € 246,539 ▲ 11% vs 2022 (€ 221,618) Favourable step	€ 245,439 Gross margin 2024: € 245,439 Unchanged (€ 246,539) Unfavourable step	€ 281,286 Gross margin 2025: € 281,286 ▲ 15% vs 2024 (€ 245,439) Favourable step	▲ 15%
Profit after taxes	€ 56,599 Profit after taxes 2022: € 56,599 First fiscal year in the series	€ 74,300 Profit after taxes 2023: € 74,300 ▲ 31% vs 2022 (€ 56,599) Favourable step	€ 74,175 Profit after taxes 2024: € 74,175 Unchanged (€ 74,300) Unfavourable step	€ 93,434 Profit after taxes 2025: € 93,434 ▲ 26% vs 2024 (€ 74,175) Favourable step	▲ 26%
Equity	€ 461,731 Equity 2022: € 461,731 First fiscal year in the series	€ 461,731 Equity 2023: € 461,731 Unchanged (€ 461,731) Unchanged	€ 461,373 Equity 2024: € 461,373 Unchanged (€ 461,731) Unfavourable step	€ 461,373 Equity 2025: € 461,373 Unchanged (€ 461,373) Unchanged
Total debts	€ 653,242 Total debts 2022: € 653,242 First fiscal year in the series	€ 673,656 Total debts 2023: € 673,656 ▲ 3% vs 2022 (€ 653,242) Unfavourable step	€ 513,937 Total debts 2024: € 513,937 ▼ 24% vs 2023 (€ 673,656) Favourable step	€ 461,659 Total debts 2025: € 461,659 ▼ 10% vs 2024 (€ 513,937) Favourable step	▼ 10%
Cash	€ 178,385 Cash 2022: € 178,385 First fiscal year in the series	€ 131,826 Cash 2023: € 131,826 ▼ 26% vs 2022 (€ 178,385) Unfavourable step	€ 64,432 Cash 2024: € 64,432 ▼ 51% vs 2023 (€ 131,826) Unfavourable step	€ 52,017 Cash 2025: € 52,017 ▼ 19% vs 2024 (€ 64,432) Unfavourable step	▼ 19%
Land & buildings	€ 236,918 Land & buildings 2022: € 236,918 First fiscal year in the series	€ 226,039 Land & buildings 2023: € 226,039 ▼ 5% vs 2022 (€ 236,918) Unchanged	€ 220,874 Land & buildings 2024: € 220,874 ▼ 2% vs 2023 (€ 226,039) Unchanged	€ 202,233 Land & buildings 2025: € 202,233 ▼ 8% vs 2024 (€ 220,874) Unchanged	▼ 8%
Retained profit	€ 400,231 Retained profit 2022: € 400,231 First fiscal year in the series	€ 400,231 Retained profit 2023: € 400,231 Unchanged (€ 400,231) Unchanged	€ 399,873 Retained profit 2024: € 399,873 Unchanged (€ 400,231) Unfavourable step	€ 399,873 Retained profit 2025: € 399,873 Unchanged (€ 399,873) Unchanged
Dividend	€ 56,599 Dividend 2022: € 56,599 First fiscal year in the series	€ 74,300 Dividend 2023: € 74,300 ▲ 31% vs 2022 (€ 56,599) Unchanged	€ 74,533 Dividend 2024: € 74,533 Unchanged (€ 74,300) Unchanged	€ 93,434 Dividend 2025: € 93,434 ▲ 25% vs 2024 (€ 74,533) Unchanged	▲ 25%
Bank debt	€ 416,163 Bank debt 2022: € 416,163 First fiscal year in the series	€ 368,630 Bank debt 2023: € 368,630 ▼ 11% vs 2022 (€ 416,163) Favourable step	€ 321,152 Bank debt 2024: € 321,152 ▼ 13% vs 2023 (€ 368,630) Favourable step	€ 281,294 Bank debt 2025: € 281,294 ▼ 12% vs 2024 (€ 321,152) Favourable step	▼ 12%
Balance sheet total	€ 1,114,973 Balance sheet total 2022: € 1,114,973 First fiscal year in the series	€ 1,135,387 Balance sheet total 2023: € 1,135,387 ▲ 2% vs 2022 (€ 1,114,973) Unchanged	€ 975,310 Balance sheet total 2024: € 975,310 ▼ 14% vs 2023 (€ 1,135,387) Unchanged	€ 923,032 Balance sheet total 2025: € 923,032 ▼ 5% vs 2024 (€ 975,310) Unchanged	▼ 5%
Employees (FTE)	0.7 Employees (FTE) 2022: 0.7 First fiscal year in the series	0.7 Employees (FTE) 2023: 0.7 Unchanged (0.7) Unchanged	0.7 Employees (FTE) 2024: 0.7 Unchanged (0.7) Unchanged	0.7 Employees (FTE) 2025: 0.7 Unchanged (0.7) Unchanged

Key figures of APOTHEEK PELGRIMS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK PELGRIMS?

What happened at APOTHEEK PELGRIMS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 5, 2026 New annual accounts for financial year 2025: profit of € 93,434 (▲ 26% vs 2024). Source: NBB ↗
2024 Farmapel BV stepped down as director. NBB
2018 Farmapel BV became a director. NBB
May 20, 1988 New establishment in Hulshout. KBO
Apr 18, 1988 Start of the company according to the CBE. KBO

In short

From € 56,599 profit in 2022 to € 93,434 profit in 2025.

Paid € 109,629 in corporate taxes since 2022.

Best year ever: 2025, with € 93,434 profit.

Paid out € 298,865 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

FARMAPEL 100%

The stake of FARMAPEL comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK PELGRIMS

The shares are held by FARMAPEL (100%).

Directors

According to the 2025 annual accounts

Farmapel BV

Gedelegeerd bestuurder · represented by Mattias Pelgrims

since 2018 · until 2024

Shareholders

FARMAPEL

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Vennekensstraat 36a

2235 Hulshout

2.038.124.903

Vennekensstraat 36A

2235 Hulshout

Active since 20 May 1988

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

FARMAPEL same network

€ 126,017 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0434.071.832

VAT number

BE 0434.071.832

Registered office

Vennekensstraat 36a, 2235 Hulshout

Names & denominations

APOTHEEK PELGRIMS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

18 April 1988

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK PELGRIMS

Financials

What happened to APOTHEEK PELGRIMS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions